AbbVie Inc. SEC filings ABBV
AbbVie Inc. has 1,006 filings in SEC EDGAR's recent list, going back to May 9, 2017. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Nov 2, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2026 | Oct 30, 2026 |
| 3 | Initial insider ownership | Oct 23, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 5, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Other events
|
Aug 18, 2026 | Aug 18, 2026 |
| 144 | Notice of proposed sale | Aug 14, 2026 | — |
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 5, 2026 | Aug 4, 2026 |
| FWP | Free writing prospectus | Aug 5, 2026 | — |
| 424B5 | Prospectus supplement | Aug 4, 2026 | — |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 6, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 11-K | Employee savings plan report | Jun 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2026 | Jun 18, 2026 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| 144 | Notice of proposed sale | May 26, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| 8-K |
Current report
Results of operations
|
Apr 29, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 3, 2026 | Apr 3, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| ARS | Annual report to shareholders | Mar 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 23, 2026 | — |
| DEF 14A | Proxy statement | Mar 23, 2026 | May 8, 2026 |
| 4/A | Filing | Mar 11, 2026 | Feb 27, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 9, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 144 | Notice of proposed sale | Mar 6, 2026 | — |
| 4 | Insider transaction | Mar 6, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Other events
|
Mar 4, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Other events
|
Feb 26, 2026 | Feb 24, 2026 |
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| FWP | Free writing prospectus | Feb 26, 2026 | — |
| 144 | Notice of proposed sale | Feb 25, 2026 | — |
| FWP | Free writing prospectus | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 10-K | Annual report | Feb 20, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 7, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2025 | Oct 31, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 3, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2025 | Sep 11, 2025 |
| 144 | Notice of proposed sale | Aug 22, 2025 | — |
| 144 | Notice of proposed sale | Aug 21, 2025 | — |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 144 | Notice of proposed sale | Aug 8, 2025 | — |
| 4 | Insider transaction | Aug 7, 2025 | Aug 5, 2025 |
| 144 | Notice of proposed sale | Aug 5, 2025 | — |
| 10-Q | Quarterly report | Aug 4, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2025 | Jul 31, 2025 |
| 3/A | Ownership document | Jul 30, 2025 | Jul 1, 2025 |
| 3 | Initial insider ownership | Jul 11, 2025 | Jul 1, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 7, 2025 | — |
| 8-K |
Current report
Results of operations
|
Jul 3, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 11-K | Employee savings plan report | Jun 13, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 3 | Initial insider ownership | May 13, 2025 | May 9, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 13, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 25, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 3, 2025 | Apr 3, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 144 | Notice of proposed sale | Mar 31, 2025 | — |
| ARS | Annual report to shareholders | Mar 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 24, 2025 | — |
| DEF 14A | Proxy statement | Mar 24, 2025 | May 9, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| PRE 14A | Preliminary proxy statement | Mar 10, 2025 | May 9, 2025 |
| 3 | Initial insider ownership | Mar 10, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| 144 | Notice of proposed sale | Feb 28, 2025 | — |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 144 | Notice of proposed sale | Feb 28, 2025 | — |
| 144 | Notice of proposed sale | Feb 26, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 26, 2025 | Feb 26, 2025 |
| 144 | Notice of proposed sale | Feb 26, 2025 | — |
| 4 | Insider transaction | Feb 24, 2025 | Feb 20, 2025 |
| 424B5 | Prospectus supplement | Feb 20, 2025 | — |
| 144 | Notice of proposed sale | Feb 20, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 19, 2025 | Feb 18, 2025 |
| FWP | Free writing prospectus | Feb 19, 2025 | — |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 18, 2025 | — |
| 424B5 | Prospectus supplement | Feb 18, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 14, 2025 | — |
| 10-K | Annual report | Feb 14, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 14, 2025 | Feb 13, 2025 |
| 4/A | Filing | Feb 7, 2025 | Feb 15, 2024 |
| 8-K |
Current report
Other events
|
Feb 5, 2025 | Jan 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 31, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Impairment
|
Jan 10, 2025 | Jan 9, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 6, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Dec 18, 2024 | Dec 16, 2024 |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2024 | Dec 11, 2024 |
| S-8 | Employee stock plan registration | Nov 4, 2024 | — |
| S-8 | Employee stock plan registration | Nov 4, 2024 | — |
| 10-Q | Quarterly report | Nov 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 3, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABBV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- North Chicago, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1551152
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.